Compare Cytokinetics Inc (CYTK) vs Abrdn Physical Platinum Shares ETF (PPLT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Abrdn Physical Platinum Shares ETF — how do they compare? Cytokinetics Inc trades at $82.03 (market cap $11.16B), while Abrdn Physical Platinum Shares ETF trades at $14.86. The key difference: Cytokinetics Inc is trading nearer its 52-week high, Abrdn Physical Platinum Shares ETF nearer its low. Which is the better fit depends on your goals.
| CYTK | PPLT | |
|---|---|---|
Market Cap | $11.16B | — |
Sector | Technology | Commodities - Metals/Agriculture |
52-Week High | $87.26 | $25.23 |
52-Week Low | $33.23 | $11.78 |
Enterprise Value | $11.63B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Abrdn Physical Platinum Shares ETF
PPLT is a physically-backed ETF designed to track the spot price of platinum, less the Trust's expenses. It holds physical platinum bullion in secure vaults, providing investors with a liquid and cost-effective way to access the platinum market without the logistical challenges of direct ownership.
Read more on PPLT →
